Conference In: cienciavitae
Evaluation of the radiosensitizing effect of gold nanoparticles in glioblastoma
Radiolabelled Gold Nanoseeds for Glioblastoma Theranostics
10th International Symposium on the Physical, Molecular, Cellular and Medical aspects of AugerElectron Processes
— 2023
Key information
Authors:
Published in
September 2023
Abstract
Glioblastoma multiforme (GBM) is among the most aggressive cancers and remains es-sentially an incurable disease. Therefore, there is an urgent need for innovative thera-pies against GBM. To tackle this goal, we have focused on multifunctional gold nano-particles (AuNPs) for image-guided GBM chemoradiotherapy, using an unprecedented strategy that relies on the simultaneous deliv-ery of Pt(IV) prodrugs and therapeutic radio-nuclides. By considering AuNPs for the de-sign of these new theranostic tools, we took into consideration their appealing properties for medical application, such as biocompati-bility, easy functionalization with molecular vectors and good biological half-life.1-3 As a first step, we have proceeded with the synthesis, characterization and biological evaluation of AuNPs decorated with a DOTA-based chelator for coordination of medically relevant trivalent metals (e.g. 67Ga, 177Lu) and a bioactive peptide (substance P (SP) derivatives) that recognizes the neuro-kinin-1 (NK1) receptor overexpressed in GBM cells. Some of the SP-containing AuNPs were also labeled with 125I profiting from the presence of a Tyr residue in the peptide sequence. As reported in this com-munication, the studies included the evalua-tion of cellular uptake and radiocytotoxicity in GBM cells for the designed multifunction-al nanoparticles, aiming to obtain a first in-sight on their suitability as targeted na-noseeeds for the theranostics of glioblastoma
Publication details
Authors in the community:
Publication version
AO - Author's Original
Title of the publication container
10th International Symposium on the Physical, Molecular, Cellular and Medical aspects of AugerElectron Processes
Location of the conference
Institut de Recherche en Cancérologie de Montpellier- France-
Conference date start
September 6, 2023
Conference date end
September 8, 2023
Fields of Science and Technology (FOS)
chemical-sciences - Chemical sciences
Keywords
- gold nanoparticles
- ubstance P
- theranostic;
- radionuclide therapy
- glioblastoma multiforme
Publication language (ISO code)
eng - English
Rights type:
Only metadata available